RT Journal Article
SR Electronic
T1 Evaluating the impact of international airline suspensions on the early global spread of COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.20.20025882
DO 10.1101/2020.02.20.20025882
A1 Adiga, Aniruddha
A1 Venkatramanan, Srinivasan
A1 Schlitt, James
A1 Peddireddy, Akhil
A1 Dickerman, Allan
A1 Bura, Andrei
A1 Warren, Andrew
A1 Klahn, Brian D
A1 Mao, Chunhong
A1 Xie, Dawen
A1 Machi, Dustin
A1 Raymond, Erin
A1 Meng, Fanchao
A1 Barrow, Golda
A1 Mortveit, Henning
A1 Chen, Jiangzhuo
A1 Walke, Jim
A1 Goldstein, Joshua
A1 Wilson, Mandy L
A1 Orr, Mark
A1 Porebski, Przemyslaw
A1 Telionis, Pyrros A
A1 Beckman, Richard
A1 Hoops, Stefan
A1 Eubank, Stephen
A1 Baek, Young Yun
A1 Lewis, Bryan
A1 Marathe, Madhav
A1 Barrett, Chris
YR 2020
UL http://medrxiv.org/content/early/2020/03/02/2020.02.20.20025882.abstract
AB Global airline networks play a key role in the global importation of emerging infectious diseases. Detailed information on air traffic between international airports has been demonstrated to be useful in retrospectively validating and prospectively predicting case emergence in other countries. In this paper, we use a well-established metric known as effective distance on the global air traffic data from IATA to quantify risk of emergence for different countries as a consequence of direct importation from China, and compare it against arrival times for the first 24 countries. Using this model trained on official first reports from WHO, we estimate time of arrival (ToA) for all other countries. We then incorporate data on airline suspensions to recompute the effective distance and assess the effect of such cancellations in delaying the estimated arrival time for all other countries. Finally we use the infectious disease vulnerability indices to explain some of the estimated reporting delays.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors would like to thank members of the Network Systems Science and Advanced Computing (NSSAC) Division for interesting discussion and suggestions related to epidemic science and machine learning. This work was partially supported by National Institutes of Health (NIH) Grant 1R01GM109718, NSF BIG DATA Grant IIS-1633028, NSF DIBBS Grant ACI-1443054, DTRA subcontract/ARA S-D00189-15-TO-01-UVA, NSF Grant No.: OAC-1916805, US Centers for Disease Control and Prevention 75D30119C05935 and a collaborative seed grant from the UVA Global Infectious Disease Institute.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data except from proprietary sources used in the analysis are made available as Supplemental material. https://doi.org/10.18130/V3/Z6524P